Abbruzzese JL - Search Results

1

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.

Abbruzzese JL, Madden T, Sugarman SM, Ellis AL, Loughlin S, Hess KR, Newman RA, Zwelling LA, Raber MN. Abbruzzese JL, et al. Clin Cancer Res. 1996 Sep;2(9):1489-97. Clin Cancer Res. 1996. PMID: 9816325 Clinical Trial.

2

Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumors.

Xiong HQ, Tran HT, Madden TL, Newman RA, Abbruzzese JL. Xiong HQ, et al. Among authors: abbruzzese jl. Clin Cancer Res. 2003 Jun;9(6):2066-71. Clin Cancer Res. 2003. PMID: 12796369 Clinical Trial.

3

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, et al. Abbruzzese JL, et al. J Clin Oncol. 1991 Mar;9(3):491-8. doi: 10.1200/JCO.1991.9.3.491. J Clin Oncol. 1991. PMID: 1999720 Clinical Trial.

4

Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.

Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Hess KR, et al. Among authors: abbruzzese mc, abbruzzese jl. Clin Cancer Res. 1999 Nov;5(11):3403-10. Clin Cancer Res. 1999. PMID: 10589751

5

Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors.

Madden T, Tran HT, Beck D, Huie R, Newman RA, Pusztai L, Wright JJ, Abbruzzese JL. Madden T, et al. Among authors: abbruzzese jl. Clin Cancer Res. 2000 Apr;6(4):1293-301. Clin Cancer Res. 2000. PMID: 10778954 Clinical Trial.

6

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV Jr, Markowitz AB, Abbruzzese JL, Bready B, et al. Pazdur R, et al. Among authors: abbruzzese jl. J Clin Oncol. 1994 Nov;12(11):2296-300. doi: 10.1200/JCO.1994.12.11.2296. J Clin Oncol. 1994. PMID: 7964943 Clinical Trial.

7

Phase I study of recombinant human endostatin in patients with advanced solid tumors.

Herbst RS, Hess KR, Tran HT, Tseng JE, Mullani NA, Charnsangavej C, Madden T, Davis DW, McConkey DJ, O'Reilly MS, Ellis LM, Pluda J, Hong WK, Abbruzzese JL. Herbst RS, et al. Among authors: abbruzzese jl. J Clin Oncol. 2002 Sep 15;20(18):3792-803. doi: 10.1200/JCO.2002.11.061. J Clin Oncol. 2002. PMID: 12228199 Clinical Trial.

8

Clinical and in vitro studies of imatinib in advanced carcinoid tumors.

Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Yao JC, et al. Among authors: abbruzzese jl. Clin Cancer Res. 2007 Jan 1;13(1):234-40. doi: 10.1158/1078-0432.CCR-06-1618. Clin Cancer Res. 2007. PMID: 17200360 Clinical Trial.

9

Phase II trial of curcumin in patients with advanced pancreatic cancer.

Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Dhillon N, et al. Among authors: abbruzzese jl. Clin Cancer Res. 2008 Jul 15;14(14):4491-9. doi: 10.1158/1078-0432.CCR-08-0024. Clin Cancer Res. 2008. PMID: 18628464 Clinical Trial.

10

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer.

Dong X, Tang H, Hess KR, Abbruzzese JL, Li D. Dong X, et al. Among authors: abbruzzese jl. Cancer. 2011 Feb 1;117(3):480-91. doi: 10.1002/cncr.25612. Epub 2010 Sep 15. Cancer. 2011. PMID: 20845477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters